A Single-Cell Platform for Monitoring Viral Proteolytic Cleavage in Different Cellular Compartments.
Infectious diseases affect human health despite advances in biomedical research and drug discovery. Among these, viruses are especially difficult to tackle due to the sudden transfer from animals to humans, high mutational rates, resistance to current treatments, and the intricacies of their molecular interactions with the host. As an example of these interactions, we describe a cell-based approach to monitor specific proteolytic events executed by either the viral-encoded protease or by host proteins on the virus. We then emphasize the significance of examining proteolysis within the subcellular compartment where cleavage occurs naturally. We show the power of stable expression, highlighting the usefulness of the cell-based multiplexed approach, which we have adapted to two independent assays previously developed to monitor (a) the activity of the HIV-1-encoded protease or (b) the cleavage of the HIV-1-encoded envelope protein by the host. Multiplexing was achieved by mixing cells each carrying a different assay or, alternatively, by engineering cells expressing two assays. Multiplexing relies on the robustness of the individual assays and their clear discrimination, further enhancing screening capabilities in an attempt to block proteolytic events required for viral infectivity and spread.
Department of Biology, San Diego State University, San Diego, CA, USA.
Darin
D
Abbadessa
Department of Biology, San Diego State University, San Diego, CA, USA.
Cameron A
CA
Smurthwaite
Department of Biology, San Diego State University, San Diego, CA, USA.
Connor W
CW
Reed
Department of Biology, San Diego State University, San Diego, CA, USA.
Roland
R
Wolkowicz
HIV-1 envelope; HIV-1 protease; cell-based assay; drug discovery; multiplexing; proteolytic cleavage; viral-host interactions
PLoS One. 2013 May 14;8(5):e63286
23691010
PLoS Negl Trop Dis. 2016 Apr 12;10(4):e0004636
27070912
Science. 2016 Sep 9;353(6304):1129-32
27492477
PeerJ. 2015 Dec 17;3:e1505
26713252
Antimicrob Agents Chemother. 2012 Jul;56(7):3620-8
22508308
Curr Protoc Neurosci. 2010 Oct;Chapter 4:Unit 4.21
20938923
PLoS One. 2010 Jun 03;5(6):e10940
20532177
Virol J. 2009 Dec 07;6:217
19968865
Science. 1988 Nov 25;242(4882):1171-3
2460925
Nat Commun. 2016 May 04;7:11379
27142248
Nat Rev Microbiol. 2013 Jul;11(7):482-96
23748342
J Gen Virol. 2015 Jul;96(Pt 7):1551-69
25711963
Science. 2016 Aug 19;353(6301):823-6
27417494
J Biol Chem. 2013 May 24;288(21):14673-80
23585568
J Biol Chem. 1999 Sep 24;274(39):27666-73
10488107
Front Oncol. 2016 Jan 07;5:299
26779442
Virol J. 2015 Nov 14;12:187
26578099
Crit Rev Microbiol. 2016 Aug;42(4):535-47
25373616
J Virol. 2008 Nov;82(21):10776-91
18715923
J Biol Chem. 2009 May 22;284(21):13975-9
19189970
Cytometry A. 2014 Jan;85(1):105-13
24700576
Science. 2016 Aug 12;353(6300):aaf8160
27417495
Liver Int. 2016 Jan;36 Suppl 1:47-57
26725897
J Virol. 2015 Sep;89(17 ):8880-96
26085147
J Mol Biol. 2011 Jul 22;410(4):582-608
21762802
J Virol. 2012 Aug;86(15):7818-28
22593157
Lancet. 2016 Jan 23;387(10016):335-6
26777915
Front Microbiol. 2015 Oct 31;6:1220
26583013
Nature. 1992 Nov 26;360(6402):358-61
1360148
AIDS Rev. 2008 Apr-Jun;10(2):67-84
18615118
Assay Drug Dev Technol. 2011 Oct;9(5):465-74
21561376
Anal Biochem. 2016 Sep 1;508:124-8
27181032
Biochem J. 1996 Mar 1;314 ( Pt 2):521-32
8670066
Methods Mol Biol. 2012;827:253-70
22144280
PLoS Pathog. 2012;8(8):e1002886
22927821
Science. 1996 Apr 12;272(5259):263-7
8602510
Front Microbiol. 2014 Jun 03;5:266
24917859
Nature. 2016 Aug 4;536(7614):48-53
27338953
Retrovirology. 2005 Nov 01;2:66
16262906
Curr Opin Chem Biol. 2004 Aug;8(4):392-8
15288249
J Biomol Screen. 2015 Jun;20(5):616-26
25724189
Cell. 1988 Apr 8;53(1):55-67
2450679
Science. 2008 Mar 28;319(5871):1830-4
18369147
J Viral Hepat. 2009 Oct;16(10):705-15
19281487
Int J Mol Sci. 2015 Jul 24;16(8):16897-919
26213926
Methods Mol Biol. 2009;515:137-50
19378113
PLoS Pathog. 2014 May 29;10(5):e1004166
24874215
Arch Virol. 1995;140(8):1441-9
7661695
Front Biosci. 2003 May 01;8:d603-19
12700115
Braz J Infect Dis. 2016 Jan-Feb;20(1):91-8
26707971
J Virol. 2002 Oct;76(20):10226-33
12239298
Cell Death Differ. 2002 Nov;9(11):1172-84
12404116
Science. 2008 Mar 28;319(5871):1834-7
18369148
Science. 2016 Feb 5;351(6273):543-4
26912676
J Biomol Screen. 2010 Jan;15(1):10-20
20008126
Mol Ther Methods Clin Dev. 2016 Apr 13;3:16017
27110581
Nat Immunol. 2016 Sep;17 (9):1102-8
27339099
Rev Soc Bras Med Trop. 2016 Feb;49(1):4-10
26689277
Physiol Plant. 2012 May;145(1):224-34
22008015
J Biol Chem. 1990 Feb 15;265(5):2640-9
2406237
Curr Protoc Cytom. 2011 Jan;Chapter 6:Unit 6.31
21207359
PLoS One. 2013 Jun 19;8(6):e68835
23840860
Curr Top Microbiol Immunol. 2002;261:107-21
11892243
J Vis Exp. 2015 Apr 14;(98):null
25938804
PLoS One. 2014 Oct 28;9(10):e110354
25350399
Molecules. 2015 Dec 01;20(12):21298-312
26633328
Scientifica (Cairo). 2012;2012:238278
24278679
Crit Rev Biochem Mol Biol. 2010 Oct;45(5):351-423
20812779
Assay Drug Dev Technol. 2010 Feb;8(1):37-46
20035615
Proteomics. 2013 Oct;13(20):2976-9
23970482